zotepine
Small moleculeexperimental
Zotepine is an atypical antipsychotic drug indicated for acute and chronic schizophrenia. It has been used in Germany since 1990 and Japan since 1982. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Mar 1, 2007 (NCT00418873)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Dopamine D2 receptorANTAGONIST
DRD2 antagonist
- Dopamine D1 receptorANTAGONIST
DRD1 antagonist
Chemistry & pharmacology
Loading structure…
SMILES
CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21- Mol. weight
- 331.87 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaZotepine ↗
- ChEMBLCHEMBL285802 ↗
Also known as
- 2-chloro-11-(2-dimethylaminoethoxy)dibenzo(b,f)thiepine
- lodopin
- nipolept
- nipolept
- zoleptil
- zoleptil
- zoleptil
- zoleptil
- zoleptil
- zoleptil
- zoleptil 100
- zoleptil 25
- zoleptil 50
- zotepine
- zotepine
- zotepine
- zotepine
- zotepine
- zotepine
- zotepine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00418873 | Phase 4 | Mar 1, 2007 | Astellas, Taipei Medical University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 1 | 1 | 1 | 2007 |
| Taipei Medical University | Academic/Hospital | 1 | 0 | 1 | 2007 |
2 organizations
Page 1 / 1